# NewLimit

reported restoring "youthful function" to liver and immune cells through epigenetic reprogramming payload discovery, publishing a January/February 2026 progress update on its AI-driven discovery systems.

Source: https://en.bioecon.ru/companies/newlimit/
Updated: 2026-07-20

- Country: United States

## Technologies

- [Partial epigenetic reprogramming](https://en.bioecon.ru/technology/partial-epigenetic-reprogramming/)